Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria
- 1 May 2009
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 22 (8) , 985-988
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- High Risk for Ovarian Cancer in a Prospective Series Is Restricted to BRCA1/2 Mutation CarriersClinical Cancer Research, 2008
- Serous Tubal Intraepithelial Carcinoma: Its Potential Role in Primary Peritoneal Serous Carcinoma and Serous Cancer PreventionJournal of Clinical Oncology, 2008
- The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?American Journal of Obstetrics and Gynecology, 2008
- Adenofibroma of the Fimbria: A Common Entity That Is Indistinguishable From Ovarian AdenofibromaInternational Journal of Gynecological Pathology, 2008
- Primary Fallopian Tube Malignancies in BRCA-Positive Women Undergoing Surgery for Ovarian Cancer Risk ReductionJournal of Clinical Oncology, 2007
- Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal RelationshipAmerican Journal of Surgical Pathology, 2007
- Endometrioid Carcinoma Simultaneously Involving the Uterus and the Fallopian TubeAmerican Journal of Surgical Pathology, 2006
- Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriersGynecologic Oncology, 2006
- BRCA-Mutation–Associated Fallopian Tube CarcinomaObstetrics & Gynecology, 2005
- Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosisAmerican Journal of Obstetrics and Gynecology, 2004